The Russian Biopharmaceuticals and Biomedicine Market

The Russian Biopharmaceuticals and Biomedicine Market

From Import Substitution to Innovation

RELEASE DATE
16-Dec-2014
REGION
Europe
Research Code: 9AB9-00-15-00-00
SKU: LS00069-EU-MR_16910
$1,500.00
In stock
SKU
LS00069-EU-MR_16910
$1,500.00
Links

Pay by invoice

ENQUIRE NOW

Description

This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. This research shows the latest developments in Russian biotechnology, defines key segments and emerging leaders, and outlines government policies and support mechanisms. The base year for the study is 2013 with a forecast period of 2014 to 2018.

Table of Contents

Executive Summary (continued)

Executive Summary

Key Companies to Watch in 2015

Research Scope and Objective

Russian Economy Overview

Healthcare Market Overview

Biopharmaceuticals Market Overview

Biopharmaceuticals Market Overview (continued)

Market Drivers

Drivers—Explained

Market Restraints

Restraints—Explained

Russian Biopharmaceuticals Market—Revenue Forecast

Regulatory Environment

Complex Program for Development of Biotechnology in the Russian Federation Until 2020

Complex Program for Development of Biotechnology in the Russian Federation Until 2020 (continued)

Key Government Support Mechanisms—Overview

Key Government Support Mechanisms—Biotech Clusters

Key Government Support Mechanisms—Biotech Clusters (continued)

Key Government Support Mechanisms—Technology Platforms

Key Government Support Mechanisms—ZHNVLP List and Import Substitution

Biotechnology Investment—State Development Institutions

Biotechnology Investment—Venture Capital

Biopharmaceuticals Market—Percent Revenue Breakdown by Segment

Biopharmaceuticals Segment Overview—Cytokines

Biopharmaceuticals Segment Overview—PKI and Coagulants

Biopharmaceuticals Segment Overview—Hormones

Biopharmaceuticals Segment Overview—Monoclonal Antibodies

Vaccines Segment

Vaccines Segment (continued)

Vaccines Segment (continued)

Vaccines Segment (continued)

Vaccines Segment (continued)

Antibiotics and Bacteriophages

Antibiotics and Bacteriophages (continued)

Antibiotics and Bacteriophages (continued)

Biomedicine Market Overview

Biomedicine Market Overview (continued)

Market Drivers

Drivers—Explained

Market Restraints

Restraints—Explained

Cell Technologies, Gene Therapy, and Regenerative Medicine

Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)

Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)

Nanomedicine and Targeted Drug Delivery

Nanomedicine and Targeted Drug Delivery (continued)

Biocompatible and Biodegradable Medical Materials

Biocompatible and Biodegradable Medical Materials (continued)

Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future”

Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future” (continued)

Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future” (continued)

Diagnostics Systems, Biochips, and Biosensors

Diagnostics Systems, Biochips, and Biosensors (continued)

Diagnostics Systems, Biochips, and Biosensors (continued)

Systems Biology, Post-genomics Technologies, Bioinformatics

Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

Three Big Predictions

Legal Disclaimer

Import Substitution of Biopharmaceuticals From the ZHNVLP List

Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)

Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)

List of Acronyms

The Frost & Sullivan Story

Value Proposition

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research

2016-17 Outlook for Indian Agriculture and Rural Demand

Release Date: 18-May-16
Region: Global

Monthly CPI & WPI Inflation, April 2016

Release Date: 18-May-16
Region: Global

India Investment Tracker January–March 2016

Release Date: 18-May-16
Region: South Asia, Middle East & North Africa

Country Profile – Russia

Release Date: 13-May-16
Region: Asia Pacific

North American Protein Ingredients Market, Forecast to 2020

Release Date: 13-May-16
Region: North America

Global Economic Tracker—Insights and Trends (GET-IT)—Emerging Middle East and Africa Q2 2016

Release Date: 12-May-16
Region: South Asia, Middle East & North Africa

Middle East and North Africa Investment Tracker January-March 2016

Release Date: 11-May-16
Region: South Asia, Middle East & North Africa

Asia-Pacific Telehealth Market Outlook, Forecast to 2020

Release Date: 11-May-16
Region: Asia Pacific

Digital Transformation in the Global Food & Agriculture Market

Release Date: 9-May-2016
Region: North America
This study explores Western Europes dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical diagnostic use. Geographic segmentation covers the United Kingdom, Germany, France, Spain, Italy, Benelux, and Scandinavia. Also, the study includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market share using a base year of 2013 and a 20142018 forecast period. A list of key sequencing service providers for each country or region is included.
More Information
No Index No
Podcast No
Author Dmitry Raspopov
WIP Number 9AB9-00-15-00-00
Is Prebook No